Release Details
TransAct Technologies Reports 2017 Second Quarter Results
Reports 2017 Second Quarter Revenue of
Summary of 2017 Q2 Results |
||||||||
(In millions, except per share and percentage data) |
||||||||
Three Months Ended |
||||||||
2017 | 2016 | |||||||
Net sales | $ | 13.6 | $ | 14.8 | ||||
Gross profit | $ | 6.4 | $ | 6.0 | ||||
Gross margin | 47.3 | % | 40.4 | % | ||||
Operating income | $ | 1.3 | $ | 1.1 | ||||
Net income | $ | 0.9 | $ | 0.8 | ||||
Net income per diluted share | $ | 0.12 | $ | 0.10 | ||||
Non-GAAP(1): |
||||||||
EBITDA | $ | 1.6 | $ | 1.4 | ||||
Adjusted EBITDA | $ | 1.7 | $ | 1.6 | ||||
(1) | A reconciliation of each non-GAAP financial measure to the most comparable Generally Accepted Accounting Principles ("GAAP") financial measure can be found included with this release. See "Non-GAAP Financial Measures" below for a discussion of these metrics. | |
"TransAct strategically entered the restaurant solutions marketplace with the AccuDate 9700, allowing the Company to leverage our core technology strengths and solutions to address a large new market opportunity. Since that time we have worked closely with customers of all sizes and varying levels of menu complexity to continuously evolve the capabilities of our product portfolio to ensure that we anticipate and address their needs. As restaurant and food service operators increasingly understand and appreciate the value of our AccuDate solutions to improve back-of-house operations, we have seen a notable preference for our integrated product solutions that help them efficiently and profitably manage their operations. To address this customer preference, we launched our AccuDate XL and recently completed the integration of our terminal with industry-leading software providers CrunchTime and Jolt, resulting in a significant increase in interest for the AccuDate XL. Accordingly, TransAct made the strategic decision to implement a number of major internal sales initiatives that have positioned the Company to benefit from the XL's long-term market opportunity.
"First, we rolled out an ongoing direct marketing campaign to elevate
awareness in the AccuDate XL and drive interest in the product,
strategically timed to begin ahead of the
"During the second quarter, the increased interest in the AccuDate XL
was reflected in the nearly 94% quarterly sequential growth in
restaurant solutions net sales, our first AccuDate label and service
contract sale through
"Looking at the rest of our markets, our casino and gaming printers continue to gain share in the improving domestic gaming environment while the outlook for new Epicentral sales over the balance of 2017 is positive. Our lottery market, in particular our sales of spare parts, is benefiting from the ongoing, industry-driven shift towards longer and/or extended contracts which is keeping our global installed base of lottery printers in the field longer. This is expected to continue to create a recurring revenue market for TransAct as the more than 500,000 printers we have sold into the lottery market will need to be maintained.
"We are also beginning to see increased signs of activity in the
domestic oil and gas market as Printrex oil and gas printer sales grew
16% on a year over year basis in the 2017 second quarter and Printrex
consumable sales through
Review of Balance Sheet and Capital Return Initiatives
As of
Summary of 2017 Second Quarter Operating Results
TransAct generated 2017 second quarter net sales of
Gross margin of 47.3% in the 2017 second quarter compared to gross
margin of 40.4% in the 2016 second quarter, reflecting a more favorable
sales mix including a significant increase in higher-margin lottery
printer spare parts sales. Higher gross margins in the 2017 second
quarter more than offset the 8% decline in net sales, resulting in a 7%
increase in gross profit to
Total operating expenses for the 2017 second quarter were
TransAct generated operating income of
2017 Second Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today,
Interested parties may also access the conference call live on the
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others in assessing the ongoing nature of what the Company's management views as TransAct's core operations. The Company believes that the non-GAAP financial measures of EBITDA and adjusted EBITDA provide relevant and useful information, which is widely used by analysts, investors and competitors in the Company's markets, as well as by the Company's management in assessing the Company's performance. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income before net interest expense, income taxes, depreciation and amortization. A reconciliation of EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income before net interest expense, income taxes, depreciation, and amortization and is adjusted for share-based compensation. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.
EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. EBITDA and adjusted EBITDA may be useful to an investor in evaluating the Company's operating performance because these measures are: (i) widely used by investors to measure a company's operating performance without regard to non-recurring items excluded from the calculation of such measure; (ii) financial measurements that are used by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company's management for various purposes including strategic planning and forecasting, assessing financial performance, and paying incentive compensation.
About
Forward-Looking Statements
Certain statements in this press release include forward-looking
statements. Forward-looking statements generally can be identified by
the use of forward-looking terminology, such as "may", "will", "expect",
"intend", "estimate", "anticipate", "believe" or "continue" or the
negative thereof or other similar words. All forward-looking statements
involve risks and uncertainties, including, but not limited to, customer
acceptance and market share gains, both domestically and
internationally, in the face of substantial competition from competitors
that have broader lines of products and greater financial resources; our
competitors introducing new products into the marketplace; our ability
to successfully develop new products; our dependence on significant
customers; our dependence on significant vendors; dependence on contract
manufacturers for the assembly of a large portion of our products in
- Financial tables follow -
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
(In thousands, except per share amounts) |
|
|
||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net sales | $ | 13,596 | $ | 14,801 | $ | 27,593 | $ | 29,158 | ||||||||
Cost of sales | 7,166 | 8,818 | 15,070 | 17,290 | ||||||||||||
Gross profit | 6,430 | 5,983 | 12,523 | 11,868 | ||||||||||||
Operating expenses: | ||||||||||||||||
Engineering, design and product development | 1,020 | 1,089 | 2,013 | 2,325 | ||||||||||||
Selling and marketing | 2,034 | 1,859 | 3,706 | 3,652 | ||||||||||||
General and administrative | 2,070 | 1,935 | 4,082 | 3,852 | ||||||||||||
5,124 | 4,883 | 9,801 | 9,829 | |||||||||||||
Operating income | 1,306 | 1,100 | 2,722 | 2,039 | ||||||||||||
Interest and other income (expense): | ||||||||||||||||
Interest, net | (8 | ) | (7 | ) | (16 | ) | (11 | ) | ||||||||
Other, net | (2 | ) | 15 | (8 | ) | 16 | ||||||||||
(10 | ) | 8 | (24 | ) | 5 | |||||||||||
Income before income taxes | 1,296 | 1,108 | 2,698 | 2,044 | ||||||||||||
Income tax provision | 429 | 355 | 888 | 666 | ||||||||||||
Net income | $ | 867 | $ | 753 | $ | 1,810 | $ | 1,378 | ||||||||
Net income per common share: | ||||||||||||||||
Basic | $ | 0.12 | $ | 0.10 | $ | 0.24 | $ | 0.18 | ||||||||
Diluted | $ | 0.12 | $ | 0.10 | $ | 0.24 | $ | 0.18 | ||||||||
Shares used in per share calculation: | ||||||||||||||||
Basic | 7,408 | 7,689 | 7,402 | 7,761 | ||||||||||||
Diluted | 7,514 | 7,743 | 7,469 | 7,813 | ||||||||||||
SUPPLEMENTAL INFORMATION - SALES BY SALES UNIT: | ||||||||||||
|
Three months ended | Six months ended | ||||||||||
|
|
|||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
Restaurant solutions | $ | 1,021 | $ | 1,715 | $ | 1,548 | $ | 2,537 | ||||
POS automation and banking | 2,048 | 3,203 | 4,506 | 5,518 | ||||||||
Casino and gaming | 3,985 | 5,154 | 9,102 | 10,592 | ||||||||
Lottery | 2,787 | 2,150 | 5,768 | 5,085 | ||||||||
Printrex | 282 | 176 | 460 | 331 | ||||||||
|
3,473 | 2,403 | 6,209 | 5,095 | ||||||||
Total net sales | $ | 13,596 | $ | 14,801 |
$ |
27,593 | $ | 29,158 | ||||
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(Unaudited) | ||||||||
|
|
|||||||
(In thousands) | 2017 | 2016 | ||||||
Assets: | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 4,877 | $ | 2,503 | ||||
Accounts receivable, net | 7,404 | 10,585 | ||||||
Inventories, net | 9,521 | 9,707 | ||||||
Other current assets | 884 | 372 | ||||||
Total current assets | 22,686 | 23,167 | ||||||
Fixed assets, net | 2,262 | 2,241 | ||||||
|
2,621 | 2,621 | ||||||
Deferred tax assets | 3,484 | 3,432 | ||||||
Intangible assets, net | 386 | 545 | ||||||
Other assets | 35 | 36 | ||||||
8,788 | 8,875 | |||||||
Total assets | $ | 31,474 | $ | 32,042 | ||||
Liabilities and Shareholders' Equity: | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 3,421 | $ | 4,894 | ||||
Accrued liabilities | 2,380 | 2,394 | ||||||
Income taxes payable | - | 19 | ||||||
Deferred revenue | 215 | 117 | ||||||
Total current liabilities | 6,016 | 7,424 | ||||||
Deferred revenue, net of current portion | 74 | 67 | ||||||
Deferred rent, net of current portion | 190 | 178 | ||||||
Other liabilities | 254 | 264 | ||||||
518 | 509 | |||||||
Total liabilities | 6,534 | 7,933 | ||||||
Shareholders' equity: | ||||||||
Common stock | 112 | 112 | ||||||
Additional paid-in capital | 29,996 | 29,701 | ||||||
Retained earnings | 24,686 | 24,157 | ||||||
Accumulated other comprehensive loss, net of tax | (102 | ) | (109 | ) | ||||
|
(29,752 | ) | (29,752 | ) | ||||
Total shareholders' equity | 24,940 | 24,109 | ||||||
Total liabilities and shareholders' equity | $ | 31,474 | $ | 32,042 | ||||
|
||||||||||||
RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA | ||||||||||||
NON-GAAP FINANCIAL MEASURES | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended | Six Months Ended | |||||||||||
(In thousands) |
|
|
||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||
Net income | $ | 867 | $ | 753 | $ | 1,810 | $ | 1,378 | ||||
Interest (income) expense, net | 8 | 7 | 16 | 11 | ||||||||
Income tax provision | 429 | 355 | 888 | 666 | ||||||||
Depreciation and amortization | 289 | 318 | 602 | 643 | ||||||||
EBITDA | 1,593 | 1,433 | 3,316 | 2,698 | ||||||||
Share-based compensation expense | 150 | 161 | 296 | 305 | ||||||||
Adjusted EBITDA | $ | 1,743 | $ | 1,594 | 3,612 | $ | 3,003 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20170803006075/en/
Investor:
President and Chief Financial Officer
203-859-6810
or
JCIR
212-835-8500 or tact@jcir.com
Source:
News Provided by Acquire Media